Sunday, November 24, 2024

TOPIC

covaxin

Another milestone achieved, India has now given 75 crore doses of Covid vaccine

India plans to vaccinate its entire eligible population by the end of 2021.

Gujarat gets into mission mode: Ankleshwar plant for Bharat Biotech releases first batch of Covaxin vaccine within two weeks of approval

Bharat Biotech had said that IIL's Ankleshwar-based production facility would add another 200 million doses to its overall vaccine production.

Total Covid-19 vaccinations in a day cross 1 crore for the first time in India, more than 62 crore doses administered so far

According to the latest data provided in the CoWIN portal, the total doses administered on August 27 was 1,00,64,032

DCGI approves study at CMC Vellore to test efficacy of mixing doses of Covaxin and Covishield vaccines

CMC Vellore will conduct a study and clinical trial to determine if a person can take two different vaccine shots of Covidshield and Covaxin to complete the vaccination course.

Careful usage by vaccinators saves 5.5 lakh Covid-19 vaccine doses in Gujarat, Ahmedabad tops the chart: Report

India has administered 47,41,32,992 Covid-19 vaccine doses till date.

How NDTV’s Sreenivasan Jain played mischief to create panic regarding Covaxin efficacy

NDTV's Sreenivasan Jain doesn't let facts get into the way of mischief that could create vaccine hesitancy and derail India's vaccination programme

Modi govt places single largest order of 66 crore Covid-19 vaccine doses, targets to vaccinate 94.4 crore people by December

Indian government placed an order for 66 crores Covid-19 vaccine doses worth Rs 14,505 crore with Serum Institute and Bharat Biotech

As Congress party allies with left parties in Brazil to claim a ‘scam’ in Covaxin deal, here is how the allegations are baseless

Opposition in Brazil forced the govt to cancel Covaxin purchase deal wrongly claiming that it was overpriced and there were irregularities in it

Bharat Biotech releases Phase-3 trials data of Covaxin: Indian-made vaccine 77.8% effective against mild cases, 93% against severe cases

Bharat Biotech announced efficacy analysis data from Phase-3 clinical trials of Covaxin, proved to be highly effective against severe cases of COVID-19

8 European nations accept Covishield in their Green Pass after India’s warning to quarantine their citizens. Details

The EU Digital covid certificate or "Green Pass" will exempt those who are fully vaccinated with a vaccine approved by the EU from mandatory quarantine. The EU "Green Pass" is expected to come into effect from July 1.

Latest News

Recently Popular